Does Charlson-Comorbidity Index Correlate with Short-Term Outcome in Patients with Gastric Cancer?;Korreliert der Charlson-Comorbidity-Index mit dem postoperativen Verlauf bei Patienten mit Magenkarzinom? Charlson-Comorbidity-Index beim Magenkarzinom

Zentralblatt fur Chirurgie

Volumn 128, Issue 11, 2003, Pages 970-976

  Lubke T ^a   Monig S P ^a   Schneider, P M ^a   Holscher A H ^a   Bollschweiler, E ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

Author keywords

Charlson Comorbidity Index; Gastric cancer; Outcome quality; Postoperative complications; Risk evaluation

Indexed keywords

ADULT; AGED; ARTICLE; CANCER STAGING; CANCER SURVIVAL; CAUSE OF DEATH; CHARLSON COMORBIDITY INDEX; COMORBIDITY; CORRELATION ANALYSIS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MULTIVARIATE ANALYSIS; POSTOPERATIVE COMPLICATION; PREVALENCE; PROGNOSIS; PROSPECTIVE STUDY; SCORING SYSTEM; STOMACH CANCER; SURGICAL MORTALITY;

ADULT; AGE FACTORS; AGED; COMORBIDITY; FEMALE; HOSPITAL MORTALITY; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PATIENT SELECTION; POSTOPERATIVE COMPLICATIONS; PREVALENCE; PROGNOSIS; PROSPECTIVE STUDIES; STOMACH NEOPLASMS; TREATMENT OUTCOME;

EID: 19244375478     PISSN: 0044409X     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2003-44805     Document Type: Article

References (34)

1. Bechstein WO, Wullstein C. Transplantation and outcome quality. Chirurg 2002; 73: 576-581
2. Beddhu S, Bruns FJ, Saul M, Seddon P, Zeidel ML. A simple comorbidity scale predicts clinical outcomes and costs in dialysis patients. Am J Med 2000; 108: 609-613
3. Beddhu S, Zeidel ML, Saul M, Seddon P, Samore MH, Stoddard GJ, Bruns FJ. The effects of comorbid conditions on the outcomes of patients undergoing peritoneal dialysis. Am J Med 2002; 112: 696-701
4. Bollschweiler E. Scoringsysteme und Qualitätsmanagement. Ekkernkamp, Scheibe (Hrsg). Qualitätsmanagement in der Medizin: Handbuch für Klinik und Praxis. Ecomed, Landsberg am Lech 2002; 1-10
5. Bollschweiler E, Siewert JR, Lorenz W, Ohmann C, Selbmann HK. Recording the postoperative course. What data are necessary? Mortality or fatality, during hospitalization, within 30 and 90 days? Langenbecks Arch Chir 1992; 377: 378-384
6. Bravo G, Dubois MF, Hebert R, De Wals P, Messier L. A prospective evaluation of the Charlson-Comorbidity Index for use in long-term care patients. J Am Geriatr Soc 2002; 50: 740-745
7. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987; 40: 373-383
8. Cleves MA, Sanchez N, Draheim M. Evaluation of two competing methods for calculating Charlson's comorbidity index when analyzing short-term mortality using administrative data. J Clin Epidemiol 1997; 50: 903-908
9. D'Hoore W, Bouckaert A, Tilquin C. Practical considerations on the use of the Charlson-comorbidity index with administrative data bases. J Clin Epidemiol 1996; 49: 1429-1433
10. D'Hoore W, Sicotte C, Tilquin C. Risk adjustment in outcome assessment: the Charlson-comorbidity index. Methods Inf Med 1993; 32: 382-387
11. Dripps R, Lamont A, Eckenhoff JD. The role of anaesthesia in surgical mortality. JAMA 1961; 178: 261-266
12. Firat S, Bousamra M, Gore E, Byhardt RW. Comorbidity and KPS are independent prognostic factors in stage I non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 2002; 52: 1047-1057
13. Firat S, Byhardt RW, Gore E. Comorbidity and Karnofksy performance score are independent prognostic factors in stage III non-small-cell lung cancer: an institutional analysis of patients treated on four RTOG studies. Radiation Therapy Oncology Group. Int J Radiat Oncol Biol Phys 2002; 54: 357-364
14. Fried L, Bernardini J, Piraino B. Charlson comorbidity index as a predictor of outcomes in incident peritoneal dialysis patients. Am J Kidney Dis 2001; 37: 337-342
15. Hall SF, Rochon PA, Streiner DL, Paszat LF, Groome PA, Rohland SL. Measuring comorbidity in patients with head and neck cancer. Laryngoscope 2002; 112: 1988-1996
16. Holscher AH, Gutschow C, Bollschweiler E. Outcome quality in visceral surgery interventions for benign illnesses. Chirurg 2002; 73: 567-575
17. Iezzoni LI. The risks of risk adjustment. Jama 1997; 278: 1600-1607
18. Jong P, Vowinckel E, Liu PP, Gong Y, Tu JV. Prognosis and determinants of survival in patients newly hospitalized for heart failure: a population-based study. Arch Intern Med 2002; 162: 1689-1694
19. Kaplan MH, Feinstein AR. The importance of classifying initial co-morbidity in evaluatin the outcome of diabetes mellitus. J Chronic Dis 1974; 27: 387-404
20. Kieszak SM, Flanders WD, Kosinski AS, Shipp CC, Karp H. A comparison of the Charlson-comorbidity index derived from medical record data and administrative billing data. J Clin Epidemiol 1999; 52: 137-142
21. Krousel-Wood MA, Abdoh A, Re R. Comparing comorbid-illness indices assessing outcome variation: the case of prostatectomy. J Gen Intern Med 1996; 11: 32-38
22. McPeek B. Measuring outcome from anaesthesia and operation. Theor Surg 1989; 1: 2-9
23. O'Connell RL, Lim LL. Utility of the Charlson-comorbidity index computed from routinely collected hospital discharge diagnosis codes. Methods Inf Med 2000; 39: 7-11
24. Reid BC, Alberg AJ, Klassen AC, Samet JM, Rozier RG, Garcia I, Winn DM. Comorbidity and survival of elderly head and neck carcinoma patients. Cancer 2001; 92: 2109-2116
25. Rieker RJ, Hammer E, Eisele R, Schmid E, Hogel J. The impact of comorbidity on the overall survival and the cause of death in patients after colorectal cancer resection. Langenbecks Arch Surg 2002; 387: 72-76
26. Siess MA. What is outcome quality? Chirurg 2002; 73: 540-544
27. Singh B, Bhaya M, Stern J, Roland JT, Zimbler M, Rosenfeld RM, Har-El G, Lucente FE. Validation of the Charlson-comorbidity index in patients with head and neck cancer: a multi-institutional study. Laryngoscope 1997; 107: 1469-1475
28. Singh B, Cordeiro PG, Santamaria E, Shaha AR, Pfister DG, Shah JP. Factors associated with complications in microvascular reconstruction of head and neck defects. Plast Reconstr Surg 1999; 103: 403-411
29. van Doorn C, Bogardus ST, Williams CS, Concato J, Towle VR, Inouye SK. Risk adjustment for older hospitalized persons: a comparison of two methods of data collection for the Charlson index. J Clin Epidemiol 2001; 54: 694-701
30. van Manen JG, Korevaar JC, Dekker FW, Boeschoten EW, Bossuyt PM, Krediet RT. How to adjust for comorbidity in survival studies in ESRD patients: a comparison of different indices. Am J Kidney Dis 2002; 40: 82-89
31. West DW, Satariano WA, Ragland DR, Hiatt RA. Comorbidity and breast cancer survival: a comparison between black and white women. Ann Epidemiol 1996; 6: 413-419
32. Wolters U, Wolf T, Stutzer H, Schroder T. ASA classification and perioperative variables as predictors of postoperative outcome. Br J Anaesth 1996; 77: 217-222
33. Siliman RA, Lash TL. Comparison of interview-based and medical-record based indices of comorbidity among breast cancer patients. Med Care 1999; 37: 339-349
34. Kobayashi K, Cooper GS, Chak A, Sivak MV Jr, Wong RC. A prospective evaluation of outcome in patients referred for PEG placement. Gastrointest Endosc 2002; 55: 500-506